Proceedings of the American Thoracic Society Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tripp, R. A.
Right arrow Articles by Alvarez, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tripp, R. A.
Right arrow Articles by Alvarez, R.
The Proceedings of the American Thoracic Society 2:147-149 (2005)
© 2005 The American Thoracic Society

Cytokines and Respiratory Syncytial Virus Infection

Ralph A. Tripp, Christine Oshansky and Rene Alvarez

Department of Infectious Diseases, University of Georgia, College of Veterinary Medicine, Athens, Georgia

Correspondence and requests for reprints should be addressed to Ralph A. Tripp, College of Veterinary Medicine, Department of Infectious Diseases, University of Georgia, Athens, GA 30602. E-mail: ratripp{at}uga.edu

Respiratory syncytial virus (RSV) is a single-stranded negative sense RNA virus in the Paramyxovirus family that is a major cause of morbidity and life-threatening lower respiratory tract disease in infants and young children worldwide. RSV is recognized as a ubiquitous virus having considerable worldwide disease burden. Studies investigating the immune response and disease pathogenesis associated with infection attribute the interplay of the virus with host factors, particularly cytokines and chemokines, in inflammation, disease, and immune effector processes. There is convincing evidence that Th1- and Th2-type cytokine patterns determine the type of immune response to RSV infection, and that the spectrum of cytokine expression affects control mechanisms involved in the regulation of disease pathogenesis and chronicity. Thus, there is a critical need to identify virus and host mechanisms that regulate cytokine expression to allow for intervention strategies to control disease pathogenesis. In this report, we discuss the role of cytokines and chemokines in the response to RSV infection, and the potential role for suppressor of cytokine signaling (SOCS) proteins in regulating these responses.

Key Words: chemokine • cytokine • protein, suppressor of cytokine signaling • virus, respiratory syncytial




This article has been cited by other articles:


Home page
J. Virol.Home page
Y. Liu, D. L. Haas, S. Poore, S. Isakovic, M. Gahan, S. Mahalingam, Z. F. Fu, and R. A. Tripp
Human Metapneumovirus Establishes Persistent Infection in the Lungs of Mice and Is Reactivated by Glucocorticoid Treatment
J. Virol., July 1, 2009; 83(13): 6837 - 6848.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. R. Murawski, G. N. Bowen, A. M. Cerny, L. J. Anderson, L. M. Haynes, R. A. Tripp, E. A. Kurt-Jones, and R. W. Finberg
Respiratory Syncytial Virus Activates Innate Immunity through Toll-Like Receptor 2
J. Virol., February 1, 2009; 83(3): 1492 - 1500.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
W. Zhang and R. A. Tripp
RNA Interference Inhibits Respiratory Syncytial Virus Replication and Disease Pathogenesis without Inhibiting Priming of the Memory Immune Response
J. Virol., December 15, 2008; 82(24): 12221 - 12231.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. M. Monick, L. S. Powers, I. Hassan, D. Groskreutz, T. O. Yarovinsky, C. W. Barrett, E. M. Castilow, D. Tifrea, S. M. Varga, and G. W. Hunninghake
Respiratory Syncytial Virus Synergizes with Th2 Cytokines to Induce Optimal Levels of TARC/CCL17
J. Immunol., August 1, 2007; 179(3): 1648 - 1658.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
D. Singh, K. L. McCann, and F. Imani
MAPK and heat shock protein 27 activation are associated with respiratory syncytial virus induction of human bronchial epithelial monolayer disruption
Am J Physiol Lung Cell Mol Physiol, August 1, 2007; 293(2): L436 - L445.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. Elliott, O. T. Lynch, Y. Suessmuth, P. Qian, C. R. Boyd, J. F. Burrows, R. Buick, N. J. Stevenson, O. Touzelet, M. Gadina, et al.
Respiratory Syncytial Virus NS1 Protein Degrades STAT2 by Using the Elongin-Cullin E3 Ligase
J. Virol., April 1, 2007; 81(7): 3428 - 3436.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
V. Bitko, A. Musiyenko, and S. Barik
Viral Infection of the Lungs through the Eye
J. Virol., January 15, 2007; 81(2): 783 - 790.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. Wagoner, M. Austin, J. Green, T. Imaizumi, A. Casola, A. Brasier, K. S. A. Khabar, T. Wakita, M. Gale Jr., and S. J. Polyak
Regulation of CXCL-8 (Interleukin-8) Induction by Double-Stranded RNA Signaling Pathways during Hepatitis C Virus Infection
J. Virol., January 1, 2007; 81(1): 309 - 318.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the American Thoracic Society.